Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGediz Ertürk, Aliye
dc.contributor.authorŞahin, Arzu
dc.contributor.authorBatı Ay, Ebru
dc.contributor.authorPelit, Emel
dc.contributor.authorBağdatlı, Emine
dc.contributor.authorKulu, İrem
dc.contributor.authorGül, Melek
dc.contributor.authorMesci, Seda
dc.contributor.authorEryılmaz, Serpil
dc.contributor.authorOba İlter, Şirin
dc.contributor.authorYıldırım, Tuba
dc.date.accessioned2021-11-01T15:06:11Z
dc.date.available2021-11-01T15:06:11Z
dc.date.issued2021
dc.identifier.citationGediz Ertürk, A., Şahin, A., Batı Ay, E., Pelit, E., Bağdatlı, Kulu, İ., Gül, M., Mesci, S., Eryılmaz, S., Oba İlter, S. & Yıldırım, T. (2021). A multidisciplinary approach to coronavirus disease (COVID-19). Molecules, 26 (12), 3526.en_US
dc.identifier.issn1420-3049
dc.identifier.urihttps://doi.org/10.3390/molecules26123526
dc.identifier.urihttps://hdl.handle.net/11491/7512
dc.description.abstractSince December 2019, humanity has faced an important global threat. Many studies have been published on the origin, structure, and mechanism of action of the SARS-CoV-2 virus and the treatment of its disease. The priority of scientists all over the world has been to direct their time to research this subject. In this review, we highlight chemical studies and therapeutic approaches to overcome COVID-19 with seven different sections. These sections are the structure and mechanism of action of SARS-CoV-2, immunotherapy and vaccine, computer-aided drug design, repurposing therapeutics for COVID-19, synthesis of new molecular structures against COVID-19, food safety/security and functional food components, and potential natural products against COVID-19. In this work, we aimed to screen all the newly synthesized compounds, repurposing chemicals covering antiviral, anti-inflammatory, antibacterial, antiparasitic, anticancer, antipsychotic, and antihistamine compounds against COVID-19. We also highlight computer-aided approaches to develop an anti-COVID-19 molecule. We explain that some phytochemicals and dietary supplements have been identified as antiviral bioproducts, which have almost been successfully tested against COVID-19. In addition, we present immunotherapy types, targets, immunotherapy and inflammation/mutations of the virus, immune response, and vaccine issues.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.relation.ispartofMoleculesen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.subjectSARS-CoV-2en_US
dc.subjectCOVID-19en_US
dc.subjectCytokine stormen_US
dc.subjectImmunotherapyen_US
dc.subjectVaccine developmenten_US
dc.subjectIn-silico researchen_US
dc.subjectSmall drugsen_US
dc.subjectRepurposing drugsen_US
dc.subjectDietary supplementsen_US
dc.subjectNatural productsen_US
dc.titleA multidisciplinary approach to coronavirus disease (COVID-19)en_US
dc.typereviewen_US
dc.departmentRektörlüken_US
dc.identifier.volume26en_US
dc.identifier.issue12en_US
dc.relation.publicationcategoryDiğer Yayınlar - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.3390/molecules26123526
dc.description.wospublicationidWOS:000666658300001en_US
dc.description.scopuspublicationid2-s2.0-85108350321en_US
dc.description.pubmedpublicationidPubMed: 34207756en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess